Day: November 4, 2020
Abstracts Include 72-Week Analysis of Phase 3 HOPE Study Supporting Long-Term Use of Oxbryta®(voxelotor)Preclinical Data Highlights Promise of GBT’s Sickle Cell Disease PipelineGBT to Host Virtual Analyst & Investor Day Event on Monday, Dec. 7, 2020SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), today announced that nine abstracts related to its sickle cell disease (SCD) programs will be presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, taking place online Dec. 5-8, 2020. The studies to be presented include the 72-week analysis of the Phase 3 HOPE Study of Oxbryta® (voxelotor) tablets and new research from GBT’s pipeline.“Nearly one year after the FDA approval of Oxbryta, we are pleased to share new clinical data supporting...
WSFS Management to Hold Meetings with Analysts and Investors at the Piper Sandler East Coast Financial Services Conference
Written by Customer Service on . Posted in Public Companies.
WILMINGTON, Del., Nov. 04, 2020 (GLOBE NEWSWIRE) — WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the virtual Piper Sandler East Coast Financial Services Conference, November 9, 2020. Rodger Levenson, WSFS’ Chairman, President and Chief Executive Officer, Dominic C. Canuso, Executive Vice President and Chief Financial Officer, and Steve Clark, Executive Vice President and Chief Commercial Banking Officer, will host one-on-one meetings with analysts and investors.Presentation Materials: WSFS will present the 3Q 2020 Investor Presentation, which is available on the Investor Relations section of WSFS’ website.About WSFS Financial CorporationWSFS Financial Corporation is a multi-billion-dollar financial services company. Its primary subsidiary, WSFS Bank, is the oldest and largest locally...
Orezone Files Final Base Shelf Prospectus
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Nov. 04, 2020 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX.V: ORE OTCQX: ORZCF) announces that it has filed a final short form base shelf prospectus (the “Final Shelf Prospectus”) with the securities regulatory authorities in in each of the provinces of Canada, other than Quebec.The Final Shelf Prospectus enables the Company to offer and issue up to C$150 million of common shares, warrants, subscription receipts, units and debt securities or a combination thereof (collectively, the “Securities”). The Securities may be issued from time to time, separately or together, in amounts, at prices, and on terms to be determined based on market conditions at the time of the offering and as set out in an accompanying prospectus supplement, during the 25-month period that the Final Shelf Prospectus remains effective....
Werner Named a Finalist for Hiring Our Heroes Military Spouse Employment and Mentoring Award
Written by Customer Service on . Posted in Public Companies.
OMAHA, Neb., Nov. 04, 2020 (GLOBE NEWSWIRE) — Werner Enterprises (NASDAQ: WERN), a premier transportation and logistics provider, is honored to be named as a finalist for the Hiring Our Heroes (HOH) Military Spouse Employment and Mentoring Award.In 2011, the Hiring Our Heroes initiative was launched by the U.S. Chamber of Commerce Foundation. It’s a nationwide effort to employ and connect veterans, service members and military spouses to employment opportunities.The 2020 Military Spouse Employment and Mentoring Award recipient will be announced at the 10th Annual Lee Anderson Awards Gala on Nov. 18, 2020. This award recognizes a company or organization for its leadership and commitment to hiring military spouses. Other criteria include remote and flexible work opportunities, working to keep military spouses employed through change-of-duty...
MacroGenics Announces Flotetuzumab and Tebotelimab Presentations at the ASH Annual Meeting 2020
Written by Customer Service on . Posted in Public Companies.
ROCKVILLE, MD, Nov. 04, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced six clinical and preclinical abstracts related to acute myeloid leukemia (AML) and flotetuzumab, an investigational bispecific CD123 × CD3 DART® molecule, and one abstract related to tebotelimab, an investigational bispecific PD-1 × LAG-3 DART molecule, to be presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, December 5-8, 2020.“We look forward to presenting clinical and biomarker results for flotetuzumab in patients with relapsed or refractory acute myeloid leukemia at the 2020 ASH annual meeting,” said Scott Koenig, M.D., Ph.D., President...
Hanna Closes Private Placement
Written by Customer Service on . Posted in Public Companies.
TORONTO, Nov. 04, 2020 (GLOBE NEWSWIRE) — Hanna Capital Corp. (the “Corporation”) (TSX Venture: HCC, Frankfurt: 04U1) is pleased to announce that, further to its press release dated March 23, 2020, the Corporation issued an aggregate of 10,000,000 units (the “Units”) of the Corporation at a price of $0.05 per Unit for aggregate gross proceeds of $500,000. Each Unit is comprised of one (1) common share and one (1) common share purchase warrant (“Warrant”). Each Warrant entitles the holder thereof to purchase one (1) common share at an exercise price of $0.08 per Warrant at any time until 5:00 p.m. on October 23, 2022.In connection with the issuance of the Units, the Corporation paid finders’ fees of $900 in cash and issued an aggregate of 18,000 broker warrants (the “Broker Warrants”) to an arm’s length third party. Each Broker Warrant...
Bombardier, Texas State Technical College (TSTC) Celebrate Official Registration of Bombardier Aviation Apprenticeship Program (BAAP)
Written by Customer Service on . Posted in Public Companies.
BAAP officially registered with U.S. Department of Labor (DOL), gains national standing and accreditationDOL accreditation enables Bombardier to attract talented individuals to apprenticeship program from the U.S. and grow dedicated talent poolBAAP supports growth of Global 7500 advanced metal wing manufacturing in Red Oak, Texas, and increases local grassroots aerospace pipelineRED OAK, Texas, Nov. 04, 2020 (GLOBE NEWSWIRE) — Bombardier today announced that its apprenticeship training program in association with Texas State Technical College (TSTC) in Red Oak, Texas, has received official registration by the U.S. Department of Labor. With this important designation, Bombardier can expand its search for talented individuals from across the U.S. to maximize its talent pool and drive regional aerospace growth for the manufacture of...
Bombardier et le collège technique de l’État du Texas (TSTC) célèbrent l’agrément officiel du programme d’apprentis de Bombardier Aviation (BAAP)
Written by Customer Service on . Posted in Public Companies.
Le programme BAAP, officiellement enregistré auprès du département du Travail des États-Unis obtient un statut et un agrément à l’échelle nationaleL’agrément du département du Travail permet à Bombardier d’attirer des personnes talentueuses des États-Unis dans un programme d’apprentissage et d’accroître son bassin de talent dédiéLe BAAP soutient la croissance de la fabrication de l’aile en métal de l’avion Global 7500 à Red Oak (Texas) et renforce la filière locale en aéronautiqueRED OAK, Texas, 04 nov. 2020 (GLOBE NEWSWIRE) — Bombardier a annoncé aujourd’hui que son programme de formation en apprentissage en association avec le collège technique de l’État du Texas (TSTC) à Red Oak (Texas) a reçu l’agrément officiel du département du Travail des États-Unis. Grâce à cette importante désignation, Bombardier peut étendre sa recherche...
Festi hf.: Financial results for Q3 2020
Written by Customer Service on . Posted in Public Companies.
Profit in Q3 2020 ISK 1,162 millionMain resultsMargin from sales of goods and services was ISK 5,831 million compared to ISK 5,644 million in Q3 2019, an increase of 3.3%.EBITDA ISK 2,586 million compared to ISK 2,617 million in Q3 2019, a decrease of 1.2%.Decline in results is related to COVID-19 restrictions enforced beginning of AugustGross margin from sales 24.8% in Q3 2020 compared to 23.4% in Q3 2019Equity ISK 29,682 million and equity ratio 34.8% compared to 35.3% at the end of 2019.Net interest-bearing debt without lease liabilities ISK 28,109 million compared to ISK 28,011 million at the end of 2019.EBITDA guidance for 2020 is updated and is in the range between ISK 7,200 – 7,500 millionEggert Þór Kristófersson, CEO of Festi:“The operations performed well in third quarter, a confirmation of the strength of brands within the Festi...
Festi hf.: Afkoma á 3. ársfjórðungi 2020
Written by Customer Service on . Posted in Public Companies.
Hagnaður 1.162 milljónir króna á 3. ársfjórðungi 2020Helstu niðurstöðurFramlegð af vöru- og þjónustusölu í 3F 2020 voru 5.831 m.kr. samanborið við 5.644 m.kr. í 3F 2019, sem samsvarar 3,3% aukningu milli ára.EBITDA nam 2.586 m.kr. á 3F 2020 samanborið við 2.617 m.kr. 3F 2019, sem jafngildir 1,2% lækkun.Lakari niðurstöðu má rekja til áhrifa COVID-19 samkomutakmarkana sem komu til í ágúst 2020.Framlegð af vörusölu var 24,8% á 3F 2020 en framlegðin var 23,4% á 3F 2019Eigið fé í lok 3F 2020 var 29.682 m.kr. og eiginfjárhlutfall 34,8% samanborið við 35,3% í lok árs 2019.Nettó vaxtaberandi skuldir án leiguskuldbindingar var 28.109 m.kr. í lok 3F 2020 samanborið við 28.011 m.kr. í lok 2019.EBITDA spá fyrir árið 2020 er nú uppfærð og er á bilinu 7.200 – 7.500 m.kr. Áfram er óvissa um áhrif COVID-19 samkomutakmarkana á reksturinn.Eggert Þór Kristófersson,...